Literature DB >> 4464837

The effect of oxytetracycline on insulin resistance in obese mice.

N Bégin-Heck, M Bourassa, H M Heick.   

Abstract

1. Chronic oxytetracycline treatment was found to improve the insulin resistance of the obese-hyperglycaemic mouse. 2. The improved response to insulin was accompanied by decreased concentrations of circulating insulin and glucose, by a decrease in the lipid content of the liver and by an increase in the insulin-receptor sites of the liver and adipose tissue. 3. The increase in insulin-receptor sites preceded the fall in blood glucose. 4. Comparable studies done on food-restricted animals indicated that although chronic food restriction corrected the hyperinsulinaemia it did not restore the insulin-receptor sites or the hyperglycaemia.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4464837      PMCID: PMC1168310          DOI: 10.1042/bj1420465

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Effect of alloxan on obese hyperglycaemic mice.

Authors:  J SOLOMON; J MAYER
Journal:  Nature       Date:  1962-01-13       Impact factor: 49.962

2.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.

Authors:  C R Kahn; D M Neville; J Roth
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

3.  On the effect of chloramphenicol and oxytetracycline on the biogenesis of mammalian mitochondria.

Authors:  H de Vries; A M Kroon
Journal:  Biochim Biophys Acta       Date:  1970-04-15

4.  Amelioration of insulin resistance in obese mice.

Authors:  R J Mahler; O Szabo
Journal:  Am J Physiol       Date:  1971-10

5.  Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.

Authors:  P Freychet; R Kahn; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

6.  Unmasking of insulin receptors in fat cells and fat cell membranes. Perturbation of membrane lipids.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1971-11       Impact factor: 5.157

7.  Insulin response in pancreatectomized dogs treated with oxytetracycline.

Authors:  N Hiatt; G Bonorris
Journal:  Diabetes       Date:  1970-05       Impact factor: 9.461

8.  Hormonal control of intermediary metabolism in obese hyperglycemic mice. II. Levels of plasma free fatty acid and immunoreactive insulin and liver glycogen.

Authors:  R R Abraham; E Dade; J Elliott; D A Hems
Journal:  Diabetes       Date:  1971-08       Impact factor: 9.461

9.  Hypoghycaemic effect of oxytetracycline.

Authors:  J B Miller
Journal:  Br Med J       Date:  1966-10-22

10.  Insulin--receptor interactions in adipose tissue cells: direct measurement and properties.

Authors:  P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

View more
  4 in total

1.  The effect of oxytetracycline on the response to insulin of diaphragm muscle and on lipid synthesis in vivo and in vitro in the ob/ob mouse.

Authors:  N Bégin-Heick; H M Heick
Journal:  Diabetologia       Date:  1976-03       Impact factor: 10.122

2.  Age dependent effects of oxytetracycline in ob/ob mice.

Authors:  P U Dubuc; P L Willis
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

3.  Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy.

Authors:  M B Davidson; S A Kaplan
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

4.  Low dose doxycycline decreases systemic inflammation and improves glycemic control, lipid profiles, and islet morphology and function in db/db mice.

Authors:  Na Wang; Xiong Tian; Yu Chen; Hui-Qi Tan; Pei-Jian Xie; Shao-Jun Chen; Yu-Cai Fu; Yi-Xin Chen; Wen-Can Xu; Chi-Ju Wei
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.